---
figid: PMC5587385__nihms891907f7
figlink: /pmc/articles/PMC5587385/figure/F7/
number: FIGURE 7
caption: IFN-α stimulation in HUVECs leads to enhanced NF-kB signaling and upregulation
  of miR-155. MiR-155 may be, in part responsible for IFN-α mediated eNOS mRNA destabilization
  leading to reduced protein expression. IFN-α elicits an immune response through
  suppression of NO and subsequent increases in MCP-1, ICAM-1 and VCAM-1. It is well
  established that insulin activates eNOS through the PI3K/Akt pathway leading to
  phosphorylation of eNOS at the Serine 1177 site and subsequent increases in NO production.
  However, in the presence of IFN-α, enhanced NO production is lost. This suggest
  that IFN-α may induce insulin resistance in HUVECs.
pmcid: PMC5587385
papertitle: 'Interferon-α Negatively Regulates the Expression of Endothelial Nitric
  Oxide Synthase and Nitric Oxide Production: Implications for SLE.'
reftext: Joy Jones Buie, et al. J Immunol. ;199(6):1979-1988.
pmc_ranked_result_index: '29049'
pathway_score: 0.9608931
filename: nihms891907f7.jpg
figtitle: 'InterferonA Negatively Regulates the Expression of Endothelial Nitric Oxide
  Synthase and Nitric Oxide Production: Implications for SLE'
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5587385__nihms891907f7.html
  '@type': Dataset
  description: IFN-α stimulation in HUVECs leads to enhanced NF-kB signaling and upregulation
    of miR-155. MiR-155 may be, in part responsible for IFN-α mediated eNOS mRNA destabilization
    leading to reduced protein expression. IFN-α elicits an immune response through
    suppression of NO and subsequent increases in MCP-1, ICAM-1 and VCAM-1. It is
    well established that insulin activates eNOS through the PI3K/Akt pathway leading
    to phosphorylation of eNOS at the Serine 1177 site and subsequent increases in
    NO production. However, in the presence of IFN-α, enhanced NO production is lost.
    This suggest that IFN-α may induce insulin resistance in HUVECs.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IFNA13
  - IFNA8
  - IFNA16
  - ICAM1
  - IFNA17
  - IFNA14
  - NOS3
  - NFKB2
  - PIK3CA
  - IFNA10
  - CCL2
  - PIK3R4
  - PIK3CG
  - PIK3CB
  - IRS2
  - PIK3CD
  - IFNA7
  - PIK3R3
  - VCAM1
  - IFNA21
  - IFNA4
  - IFNA5
  - IFNA6
  - AKT3
  - NFKB1
  - REL
  - IFNA1
  - IRF9
  - AKT2
  - PIK3R5
  - PIK3R6
  - RELA
  - RELB
  - IFNA2
  - AKT1
  - Nitric Oxide
  - Cancer
genes:
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA13
  entrez: '3447'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA8
  entrez: '3445'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA16
  entrez: '3449'
- word: ICAM-1
  symbol: ICAM1
  source: hgnc_symbol
  hgnc_symbol: ICAM1
  entrez: '3383'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA17
  entrez: '3451'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA14
  entrez: '3448'
- word: ENOS
  symbol: eNOS
  source: hgnc_alias_symbol
  hgnc_symbol: NOS3
  entrez: '4846'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA10
  entrez: '3446'
- word: MCP-1
  symbol: MCP-1
  source: hgnc_alias_symbol
  hgnc_symbol: CCL2
  entrez: '6347'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: IRS-1/2
  symbol: IRS2
  source: hgnc_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA7
  entrez: '3444'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: VCAM-1
  symbol: VCAM1
  source: hgnc_symbol
  hgnc_symbol: VCAM1
  entrez: '7412'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA21
  entrez: '3452'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA4
  entrez: '3441'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA5
  entrez: '3442'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA6
  entrez: '3443'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: IRF-9
  symbol: IRF9
  source: hgnc_symbol
  hgnc_symbol: IRF9
  entrez: '10379'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA2
  entrez: '3440'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
chemicals:
- word: Nitric Oxide
  source: MESH
  identifier: D009569
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
